C34H36F2N8O8
Neat
722.71
1391918-18-5; UNII-4R5S14FD9Y; 4R5S14FD9Y; DES(5-methyl-1, 3, 4-oxadiazol)raltegravir dimer; Raltegravir potassium impurity H [EP]; N, N'-bis[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]oxamide; N1, N2-bis[1-[4-[[[(4-Fluorophenyl)methyl]amino]carbonyl]-1, 6-dihydro-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl]-1-methylethyl]ethanediamide; Ethanediamide, N1, N2-bis(1-(4-((((4-fluorophenyl)methyl)amino)carbonyl)-1, 6-dihydro-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl)-1-methylethyl)-; N, N-Bis(2-(4-(((4-fluorophenyl)methyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1, 6-dihydropyrimidin-2-yl)propan-2-yl)oxamide; N1, N2-Bis(2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1, 6-dihydropyrimidin-2-yl)propan-2-yl)oxalamide; N1, N2-bis[1-[4-[[[(4-Fluorophenyl)methyl]amino]carbonyl]-1, 6-dihydro-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl]-1-methylethyl]ethanediamide (>85%); C34H36F2N8O8; RALTEGRAVIR POTASSIUM IMPURITY H [EP IMPURITY]; N and N'-bis[1-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxo-pyrimidin-2-yl]-1-methyl-ethyl]oxamide
N and N'-bis[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]oxamide
InChI=1S/C34H36F2N8O8/c1-33(2,31-39-21(23(45)29(51)43(31)5)25(47)37-15-17-7-11-19(35)12-8-17)41-27(49)28(50)42-34(3,4)32-40-22(24(46)30(52)44(32)6)26(48)38-16-18-9-13-20(36)14-10-18/h7-14,45-46H,15-16H2,1-6H3,(H,37,47)(H,38,48)(H,41,49)(H,42,50)